Skip to main content
Erschienen in: Journal of Gastroenterology 11/2012

01.11.2012 | Review

Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model

verfasst von: Cristina Stasi, Massimo Rosselli, Massimo Bellini, Giacomo Laffi, Stefano Milani

Erschienen in: Journal of Gastroenterology | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

The interaction between the brain and the gut as a pathological mechanism of functional gastrointestinal disorders has been recently recognized in the pathophysiology of the irritable bowel syndrome. Communication between central nervous system and enteric nervous system is two-directional: the brain can influence the function of the enteric nervous system and the gut can influence the brain via vagal and sympathetic afferents. In patients with irritable bowel syndrome, symptoms may be caused by alterations either primarily in the central nervous system (top-down model), or in the gut (bottom-up model), or in a combination of both. The brain–gut axis may be stimulated by various stressors either directed to the central nervous system (exteroreceptive stress) or to the gut (interoceptive stress). Particularly, clinical evidence suggest that in complex and multifactorial diseases such as irritable bowel syndrome, psychological disorders represent significant factors in the pathogenesis and course of the syndrome. Neuroimaging techniques have shown functional differences between central process in healthy subjects and patients with irritable bowel syndrome. Moreover, a high prevalence of psychological/psychiatric disorders have been reported in IBS patients compared to controls. Several data also suggest an alteration of neuro-endocrine and autonomic output to the periphery in these patients. This review will examine and discuss the complex interplay of neuro-endocrine–immune pathways, closely associated with neuropsychiatric disorders.
Literatur
1.
2.
Zurück zum Zitat Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis in inflammatory bowel disease? J Neuroimmunol. 2002;126:116–25.PubMedCrossRef Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis in inflammatory bowel disease? J Neuroimmunol. 2002;126:116–25.PubMedCrossRef
3.
Zurück zum Zitat Stasi C, Orlandelli E. Role of the brain–gut axis in the pathophysiology of Crohn’s disease. Dig Dis. 2008;26:156–66.PubMedCrossRef Stasi C, Orlandelli E. Role of the brain–gut axis in the pathophysiology of Crohn’s disease. Dig Dis. 2008;26:156–66.PubMedCrossRef
4.
Zurück zum Zitat Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999;45:1–5.CrossRef Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999;45:1–5.CrossRef
5.
Zurück zum Zitat Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.PubMedCrossRef Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.PubMedCrossRef
6.
Zurück zum Zitat Lovallo WR, Thomas TL. Stress hormones in psychophysiological research: emotional, behavioral, and cognitive implications. In: Cacioppo JT, Tassinary LG, Berntson GG, editors. Handbook of psychophysiology. Cambridge: Cambridge University Press; 2000. p. 342–67. Lovallo WR, Thomas TL. Stress hormones in psychophysiological research: emotional, behavioral, and cognitive implications. In: Cacioppo JT, Tassinary LG, Berntson GG, editors. Handbook of psychophysiology. Cambridge: Cambridge University Press; 2000. p. 342–67.
7.
Zurück zum Zitat Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep. 2003;5:343–50.PubMedCrossRef Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep. 2003;5:343–50.PubMedCrossRef
8.
Zurück zum Zitat Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993;34:229–34.PubMedCrossRef Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993;34:229–34.PubMedCrossRef
9.
Zurück zum Zitat Thijssen AY, Jonkers DM, Leue C, van der Veek PP, Vidakovic-Vukic M, van Rood YR, et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol. 2010;44:e236–41.PubMedCrossRef Thijssen AY, Jonkers DM, Leue C, van der Veek PP, Vidakovic-Vukic M, van Rood YR, et al. Dysfunctional cognitions, anxiety and depression in irritable bowel syndrome. J Clin Gastroenterol. 2010;44:e236–41.PubMedCrossRef
10.
Zurück zum Zitat Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol. 1997;9:345–52.PubMedCrossRef Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility. Eur J Gastroenterol Hepatol. 1997;9:345–52.PubMedCrossRef
11.
Zurück zum Zitat Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256–61.PubMedCrossRef Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256–61.PubMedCrossRef
12.
Zurück zum Zitat O’Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain–gut axis dysfunction. Psychopharmacology (Berl). 2011;214:71–88.CrossRef O’Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain–gut axis dysfunction. Psychopharmacology (Berl). 2011;214:71–88.CrossRef
13.
Zurück zum Zitat Irwin C, Falsetti SA, Lydiard RB, Ballenger JC, Brock CD, Brener W. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry. 1996;57:576–8.PubMedCrossRef Irwin C, Falsetti SA, Lydiard RB, Ballenger JC, Brock CD, Brener W. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry. 1996;57:576–8.PubMedCrossRef
14.
Zurück zum Zitat Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy with irritable bowel syndrome. Gut. 1990;31:896–8.PubMedCrossRef Prior A, Colgan SM, Whorwell PJ. Changes in rectal sensitivity after hypnotherapy with irritable bowel syndrome. Gut. 1990;31:896–8.PubMedCrossRef
15.
Zurück zum Zitat Poitras P, Riberdy Poitras M, Boivin M, Verrier P. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002;47:914–20.PubMedCrossRef Poitras P, Riberdy Poitras M, Boivin M, Verrier P. Evolution of visceral sensitivity in patients with irritable bowel syndrome. Dig Dis Sci. 2002;47:914–20.PubMedCrossRef
16.
Zurück zum Zitat Houghton LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ. Visceral sensation and emotion: a study using hypnosis. Gut. 2002;51:701–4.PubMedCrossRef Houghton LA, Calvert EL, Jackson NA, Cooper P, Whorwell PJ. Visceral sensation and emotion: a study using hypnosis. Gut. 2002;51:701–4.PubMedCrossRef
17.
Zurück zum Zitat Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain–gut interactions. Med Sci Monit. 2004;10:RA55–62. Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain–gut interactions. Med Sci Monit. 2004;10:RA55–62.
18.
Zurück zum Zitat Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64–72.PubMedCrossRef Silverman DH, Munakata JA, Ennes H, Mandelkern MA, Hoh CK, Mayer EA. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology. 1997;112:64–72.PubMedCrossRef
19.
Zurück zum Zitat Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754–61.PubMedCrossRef Drossman DA, Ringel Y, Vogt BA, Leserman J, Lin W, Smith JK, et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology. 2003;124:754–61.PubMedCrossRef
20.
Zurück zum Zitat Mertz H, Morgan V, Tanner G, Pichens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842–8.PubMedCrossRef Mertz H, Morgan V, Tanner G, Pichens D, Price R, Shyr Y, et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology. 2000;118:842–8.PubMedCrossRef
21.
Zurück zum Zitat Baciu MV, Bonaz BL, Papillon E, Bost RA, Le Bas JF, Fournet J, et al. Central processing of rectal pain: a functional MR imaging study. Am J Neuroradiol. 1999;20:1920–4.PubMed Baciu MV, Bonaz BL, Papillon E, Bost RA, Le Bas JF, Fournet J, et al. Central processing of rectal pain: a functional MR imaging study. Am J Neuroradiol. 1999;20:1920–4.PubMed
22.
Zurück zum Zitat Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654–61.PubMedCrossRef Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002;97:654–61.PubMedCrossRef
23.
Zurück zum Zitat Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117:854–66.PubMed Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med. 1992;117:854–66.PubMed
24.
Zurück zum Zitat Gue M, Tekamp A, Tabis N, Junien JL, Buéno L. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala. Brain Res. 1994;658:232–8.PubMedCrossRef Gue M, Tekamp A, Tabis N, Junien JL, Buéno L. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala. Brain Res. 1994;658:232–8.PubMedCrossRef
25.
Zurück zum Zitat Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38:225–34.PubMedCrossRef Sajdyk TJ, Shekhar A, Gehlert DR. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides. 2004;38:225–34.PubMedCrossRef
26.
Zurück zum Zitat Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36:165–86.PubMedCrossRef Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 1983;36:165–86.PubMedCrossRef
27.
Zurück zum Zitat Taché Y, Monnikes H, Bonaz B, Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann NY Acad Sci. 1993;697:233–43.PubMedCrossRef Taché Y, Monnikes H, Bonaz B, Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann NY Acad Sci. 1993;697:233–43.PubMedCrossRef
28.
Zurück zum Zitat Taché Y, Martinez V, Million M, Rivier J. Corticotropin-releasing factor and the brain–gut motor response to stress. Can J Gastroenterol. 1999;13:18A–25A.PubMed Taché Y, Martinez V, Million M, Rivier J. Corticotropin-releasing factor and the brain–gut motor response to stress. Can J Gastroenterol. 1999;13:18A–25A.PubMed
29.
Zurück zum Zitat Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20:1093–102.PubMedCrossRef Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 1998;20:1093–102.PubMedCrossRef
30.
Zurück zum Zitat Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat Genet. 1998;19:162–6.PubMedCrossRef Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat Genet. 1998;19:162–6.PubMedCrossRef
31.
Zurück zum Zitat Cole MA, Kalman BA, Pace TW, Topczewski F, Lowrey MJ, Spencer RL. Selective blockade of the mineralocorticoid receptor impairs hypothalamic–pituitary–adrenal axis expression of habituation. J Neuroendocrinol. 2000;12:1034–42.PubMedCrossRef Cole MA, Kalman BA, Pace TW, Topczewski F, Lowrey MJ, Spencer RL. Selective blockade of the mineralocorticoid receptor impairs hypothalamic–pituitary–adrenal axis expression of habituation. J Neuroendocrinol. 2000;12:1034–42.PubMedCrossRef
32.
Zurück zum Zitat Munakata J, Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, et al. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology. 1998;114:A808.CrossRef Munakata J, Mayer EA, Chang L, Schmulson M, Liu M, Tougas G, et al. Autonomic and neuroendocrine responses to recto-sigmoid stimulation. Gastroenterology. 1998;114:A808.CrossRef
33.
Zurück zum Zitat Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods NF, et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol. 1996;91:906–13.PubMed Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods NF, et al. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol. 1996;91:906–13.PubMed
34.
Zurück zum Zitat Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–81.PubMedCrossRef Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary–adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–81.PubMedCrossRef
35.
Zurück zum Zitat Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.PubMedCrossRef Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35.PubMedCrossRef
36.
Zurück zum Zitat Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci. 1995;771:1–18.PubMedCrossRef Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci. 1995;771:1–18.PubMedCrossRef
37.
Zurück zum Zitat Spiller RC, Jenkis D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.PubMedCrossRef Spiller RC, Jenkis D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.PubMedCrossRef
38.
Zurück zum Zitat Creed F. The relationship between psychosocial parameters and outcome in the irritable bowel syndrome. Am J Med. 1999;107:74–80.CrossRef Creed F. The relationship between psychosocial parameters and outcome in the irritable bowel syndrome. Am J Med. 1999;107:74–80.CrossRef
39.
Zurück zum Zitat Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–6.PubMedCrossRef Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–6.PubMedCrossRef
40.
Zurück zum Zitat Aggarwal A, Cutts TF, Abell AL, Cardoso S, Familoni B, Bremer J, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994;106:945–50.PubMed Aggarwal A, Cutts TF, Abell AL, Cardoso S, Familoni B, Bremer J, et al. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology. 1994;106:945–50.PubMed
41.
Zurück zum Zitat Tougas G. The autonomic nervous system in functional bowel disorders. Gut. 2000;47:iv78–80. Tougas G. The autonomic nervous system in functional bowel disorders. Gut. 2000;47:iv78–80.
42.
Zurück zum Zitat Heitkemper M, Jarret M, Cain KC, Burr R, Levy RL, Feld A, et al. Autonomic nervous system in women with irritable bowel syndrome. Dig Dis Sci. 2001;46:1276–84.PubMedCrossRef Heitkemper M, Jarret M, Cain KC, Burr R, Levy RL, Feld A, et al. Autonomic nervous system in women with irritable bowel syndrome. Dig Dis Sci. 2001;46:1276–84.PubMedCrossRef
43.
Zurück zum Zitat Elsenbruch S, Orr WC. Diarrhea and constipation-predominant IBS patients in postprandrial autonomic and cortisol responses. Am J Gastroenterol. 2001;96:460–6.PubMedCrossRef Elsenbruch S, Orr WC. Diarrhea and constipation-predominant IBS patients in postprandrial autonomic and cortisol responses. Am J Gastroenterol. 2001;96:460–6.PubMedCrossRef
44.
45.
Zurück zum Zitat Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in irritable bowel syndrome. Dig Dis Sci. 2002;47:1716–22.PubMedCrossRef Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in irritable bowel syndrome. Dig Dis Sci. 2002;47:1716–22.PubMedCrossRef
46.
Zurück zum Zitat Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98:1354–61.PubMedCrossRef Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98:1354–61.PubMedCrossRef
47.
Zurück zum Zitat Jarret ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2003;48:386–94.CrossRef Jarret ME, Burr RL, Cain KC, Hertig V, Weisman P, Heitkemper MM. Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome. Dig Dis Sci. 2003;48:386–94.CrossRef
48.
Zurück zum Zitat Isgar B, Harman M, Kaye MD, Whorwel PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190–2.PubMedCrossRef Isgar B, Harman M, Kaye MD, Whorwel PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190–2.PubMedCrossRef
49.
Zurück zum Zitat Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Gut. 2000;47:804–11.CrossRef Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Gut. 2000;47:804–11.CrossRef
50.
Zurück zum Zitat Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol. 1989;88:70–8.PubMedCrossRef Church MK, Lowman MA, Robinson C, Holgate ST, Benyon RC. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol. 1989;88:70–8.PubMedCrossRef
51.
Zurück zum Zitat Arzubiaga C, Morrow J, Roberts LJ, Biaggioni I. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. J Allergy Clin Immunol. 1991;87:88–93.PubMedCrossRef Arzubiaga C, Morrow J, Roberts LJ, Biaggioni I. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. J Allergy Clin Immunol. 1991;87:88–93.PubMedCrossRef
52.
Zurück zum Zitat Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol. 1998;13:980–9.PubMedCrossRef Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol. 1998;13:980–9.PubMedCrossRef
53.
Zurück zum Zitat Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.PubMed Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000;52:595–638.PubMed
54.
Zurück zum Zitat Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3:S25–34.PubMed Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3:S25–34.PubMed
55.
Zurück zum Zitat Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gastroenterology. 2002;51:i29–33. Mertz H. Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gastroenterology. 2002;51:i29–33.
56.
Zurück zum Zitat Mayer EA, Naliboff BD, Chang L. Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis. 2001;19:212–8.PubMedCrossRef Mayer EA, Naliboff BD, Chang L. Basic pathophysiologic mechanisms in irritable bowel syndrome. Dig Dis. 2001;19:212–8.PubMedCrossRef
57.
Zurück zum Zitat Kim DY, Camilleri M. Serotonin: a mediator of the brain–gut connection. Am J Gastroenterol. 2000;95:2698–709.PubMed Kim DY, Camilleri M. Serotonin: a mediator of the brain–gut connection. Am J Gastroenterol. 2000;95:2698–709.PubMed
58.
Zurück zum Zitat Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, et al. Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53:829–37.PubMedCrossRef Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, et al. Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53:829–37.PubMedCrossRef
59.
Zurück zum Zitat Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980;25:404–13.PubMedCrossRef Whitehead WE, Engel BT, Schuster MM. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980;25:404–13.PubMedCrossRef
60.
Zurück zum Zitat Simrén M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001;48:20–7.PubMedCrossRef Simrén M, Abrahamsson H, Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut. 2001;48:20–7.PubMedCrossRef
61.
Zurück zum Zitat Slater BJ, Plusa SM, Smith AN, Varma JS. Rectal hypersensitivity in the irritable bowel syndrome. Int J Colorectal Dis. 1997;12:29–32.PubMedCrossRef Slater BJ, Plusa SM, Smith AN, Varma JS. Rectal hypersensitivity in the irritable bowel syndrome. Int J Colorectal Dis. 1997;12:29–32.PubMedCrossRef
62.
Zurück zum Zitat Harraf F, Schmulson M, Saba L, Varma JS. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut. 1998;43:388–94.PubMedCrossRef Harraf F, Schmulson M, Saba L, Varma JS. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut. 1998;43:388–94.PubMedCrossRef
63.
Zurück zum Zitat Steens J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil. 2002;14:241–7.PubMedCrossRef Steens J, Van Der Schaar PJ, Penning C, Brussee J, Masclee AA. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome. Neurogastroenterol Motil. 2002;14:241–7.PubMedCrossRef
64.
Zurück zum Zitat Tam FSF, Hiller K, Bunce K. Investigation of the 5-HT receptor type involved in inhibition of spontaneous activity of human colonic circular muscle. Br J Pharmacol. 1992;106:25P.CrossRef Tam FSF, Hiller K, Bunce K. Investigation of the 5-HT receptor type involved in inhibition of spontaneous activity of human colonic circular muscle. Br J Pharmacol. 1992;106:25P.CrossRef
65.
Zurück zum Zitat Evangelista S. Involvement of tachykinins in intestinal inflammation. Curr Pharm Des. 2001;7:19–30.PubMedCrossRef Evangelista S. Involvement of tachykinins in intestinal inflammation. Curr Pharm Des. 2001;7:19–30.PubMedCrossRef
66.
Zurück zum Zitat Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther. 1997;73:219–63.PubMedCrossRef Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther. 1997;73:219–63.PubMedCrossRef
67.
Zurück zum Zitat Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther. 1997;73:173–217.PubMedCrossRef Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther. 1997;73:173–217.PubMedCrossRef
68.
Zurück zum Zitat Leng YX, Wei YY, Chen H, Zhou SP, Yang YL, Duan LP. Alteration of cholinergic and peptidergic neurotransmitters in rat ileum induced by acute stress following transient intestinal infection is mast cell dependent. Chin Med J. 2010;123:227–33.PubMed Leng YX, Wei YY, Chen H, Zhou SP, Yang YL, Duan LP. Alteration of cholinergic and peptidergic neurotransmitters in rat ileum induced by acute stress following transient intestinal infection is mast cell dependent. Chin Med J. 2010;123:227–33.PubMed
69.
Zurück zum Zitat Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA. 1987;84:2975–9.PubMedCrossRef Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA. 1987;84:2975–9.PubMedCrossRef
70.
Zurück zum Zitat Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, et al. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig Dis Sci. 2004;49:1236–43.PubMedCrossRef Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, et al. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig Dis Sci. 2004;49:1236–43.PubMedCrossRef
71.
Zurück zum Zitat Salio C, Lossi L, Ferrini F, Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006;326:583–98.PubMedCrossRef Salio C, Lossi L, Ferrini F, Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006;326:583–98.PubMedCrossRef
72.
Zurück zum Zitat Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol. 2007;13:3027–30.PubMed Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol. 2007;13:3027–30.PubMed
73.
Zurück zum Zitat Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef
74.
Zurück zum Zitat Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to Toll-like receptors and beyond—current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:363–73.PubMedCrossRef Rodríguez-Fandiño O, Hernández-Ruiz J, Schmulson M. From cytokines to Toll-like receptors and beyond—current knowledge and future research needs in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:363–73.PubMedCrossRef
75.
Zurück zum Zitat Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–20.PubMedCrossRef Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–20.PubMedCrossRef
76.
Zurück zum Zitat Dinan TG, Quigley EM, Ahmed SM, Scully P, O’Brien S, O’Mahony L, et al. Hypothalamic–pituitary–gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304–11.PubMedCrossRef Dinan TG, Quigley EM, Ahmed SM, Scully P, O’Brien S, O’Mahony L, et al. Hypothalamic–pituitary–gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304–11.PubMedCrossRef
77.
Zurück zum Zitat Wood JD. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol. 2002;35:S11–22.PubMedCrossRef Wood JD. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol. 2002;35:S11–22.PubMedCrossRef
78.
Zurück zum Zitat Stasi C, Zignego AL, Laffi G, Rosselli M. The liver–cytokine–brain circuit in interferon-based treatment of patients with chronic viral hepatitis. J Viral Hepatitis. 2011;18:525–32.CrossRef Stasi C, Zignego AL, Laffi G, Rosselli M. The liver–cytokine–brain circuit in interferon-based treatment of patients with chronic viral hepatitis. J Viral Hepatitis. 2011;18:525–32.CrossRef
Metadaten
Titel
Altered neuro-endocrine–immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model
verfasst von
Cristina Stasi
Massimo Rosselli
Massimo Bellini
Giacomo Laffi
Stefano Milani
Publikationsdatum
01.11.2012
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 11/2012
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0627-7

Weitere Artikel der Ausgabe 11/2012

Journal of Gastroenterology 11/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.